FY 2018-19

Morepen Labs begins FY 2018-19 with a Sound Performance in the First Quarter

Company reports 93 percent rise in its consolidated net profit and 26 percent rise in its consolidated net sales revenue…

6 years ago

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home2/theprkho/public_html/thepharmatimes.in/wp-includes/functions.php on line 5420